News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
6,101 Results
Type
Article (55)
Press Release (6046)
Section
Business (2603)
Career Advice (4)
Deals (383)
Drug Development (1318)
FDA (227)
Job Trends (411)
News (4255)
Policy (225)
Tag
Academia (7)
Allergies (2)
Alliances (84)
Alzheimer's disease (38)
Approvals (239)
Best Places to Work (461)
Bladder cancer (3)
Breast cancer (8)
Cancer (73)
Cardiovascular disease (3)
Career advice (3)
CAR-T (2)
Cell therapy (4)
Cervical cancer (3)
Clinical research (1261)
Collaboration (5)
COVID-19 (10)
Data (87)
Diabetes (3)
Diagnostics (54)
Earnings (2593)
Events (618)
FDA (255)
Funding (3)
Gene therapy (6)
GLP-1 (8)
Government (24)
Healthcare (167)
Infectious disease (13)
Inflammatory bowel disease (2)
IPO (323)
Job creations (5)
Job search strategy (3)
Layoffs (3)
Legal (10)
Lung cancer (21)
Lymphoma (10)
Medical device (202)
Medtech (202)
Mergers & acquisitions (63)
Metabolic disorders (5)
Multiple sclerosis (2)
NASH (2)
Neuroscience (48)
NextGen: Class of 2025 (16)
Non-profit (20)
Northern California (53)
Obesity (2)
Parkinson's disease (4)
Peanut (2)
People (28)
Phase I (183)
Phase II (381)
Phase III (729)
Pipeline (37)
Postmarket research (86)
Preclinical (26)
Prostate cancer (2)
Radiopharmaceuticals (7)
Rare diseases (4)
Real estate (2)
Regulatory (232)
Reports (2)
Research institute (10)
Resumes & cover letters (2)
RSV (2)
Schizophrenia (2)
Southern California (19)
Startups (4)
United States (356)
Vaccines (5)
Date
Today (1)
Last 7 days (7)
Last 30 days (33)
Last 365 days (790)
2025 (25)
2024 (777)
2023 (760)
2022 (807)
2021 (873)
2020 (610)
2019 (414)
2018 (359)
2017 (269)
2016 (132)
2015 (188)
2014 (114)
2013 (69)
2012 (93)
2011 (99)
2010 (92)
Location
Arizona (3)
Asia (463)
Australia (24)
California (77)
Canada (14)
China (9)
Delaware (18)
Europe (1083)
Florida (14)
Georgia (3)
Illinois (4)
Indiana (14)
Japan (8)
Kansas (5)
Maryland (11)
Massachusetts (51)
Michigan (4)
Minnesota (3)
Missouri (2)
New Jersey (63)
New York (30)
North Carolina (8)
Northern California (53)
Pennsylvania (22)
South America (6)
Southern California (19)
Texas (11)
Utah (4)
Washington State (7)
6,101 Results for "%E2%80%9D".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge
January 7, 2025
·
4 min read
Press Releases
Jackson Pharmacy Professionals Unveils Brand Refresh and New Identity as “Jackson PharmacyPros”
December 11, 2024
·
2 min read
Press Releases
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025”
January 7, 2025
·
4 min read
Press Releases
FBB Biomed Signs Agreement with Verici Dx plc to Offer Research-Use-Only “RUO” Tests to Clinicians
December 2, 2024
·
2 min read
BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference
December 23, 2024
·
3 min read
Press Releases
Ōmcare Debuts “Phygital” Home Health Platform at CES
December 11, 2024
·
3 min read
Press Releases
U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for OJEMDA™ (tovorafenib) to Treat the Most Common Form of Childhood Brain Tumor in Pediatric Patients
January 17, 2025
·
5 min read
Press Releases
Amgen’s IMDYLLTRA®▼ (tarlatamab) Granted a Conditional Marketing Authorisation for Third-Line Treatment of Extensive-Stage Small Cell Lung Cancer in the United Kingdom
January 6, 2025
·
7 min read
Press Releases
Takeda’s FRUZAQLA™ (fruquintinib) Receives Health Canada Market Authorization for Metastatic Colorectal Cancer (mCRC)
January 20, 2025
·
6 min read
Press Releases
FDA Grants Orphan Drug Designation to IPS HEART’s GIVI-MPC Stem Cell Therapy for Becker Muscular Dystrophy
January 13, 2025
·
2 min read
1 of 611
Next
